Welcome to LookChem.com Sign In|Join Free
  • or
(R)-2-(3-{3-[(2,2-diphenylethyl)amino]-3-methyl-propoxy}-phenyl) acetic acid methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

610319-01-2

Post Buying Request

610319-01-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

610319-01-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 610319-01-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,0,3,1 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 610319-01:
(8*6)+(7*1)+(6*0)+(5*3)+(4*1)+(3*9)+(2*0)+(1*1)=102
102 % 10 = 2
So 610319-01-2 is a valid CAS Registry Number.

610319-01-2Relevant academic research and scientific papers

The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages

Marino Jr., Joseph P.,Kallander, Lara S.,Ma, Chun,Oh, Hye-Ja,Lee, Dennis,Gaitanopoulos, Dimitri E.,Krawiec, John A.,Parks, Derek J.,Webb, Christine L.,Ziegler, Kelly,Jaye, Michael,Thompson, Scott K.

scheme or table, p. 5617 - 5621 (2010/04/30)

The liver X receptors (LXR) play a key role in cholesterol homeostasis and lipid metabolism. SAR studies around tertiary-amine lead molecule 2, an LXR full agonist, revealed that steric and conformational changes to the acetic acid and propanolamine groups produce dramatic effects on agonist efficacy and potency. The new analogs possess good functional activity, demonstrating the ability to upregulate LXR target genes, as well as promote cholesterol efflux in macrophages.

ACID AND ESTER COMPOUNDS AND METHODS OF USING THE SAME

-

Page/Page column 46-47, (2008/06/13)

Disclosed is a compound of having the formula (II-A), pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and solvates of this invention are useful as LXR agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 610319-01-2